Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Jun Yang

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Proteomics|July 21, 2012
A novel quantitative proteomics workflow by isobaric terminal labelingShu-Jun Yang, Ai-Ying Nie, Lei Zhang, et al.
Oncotargets and Therapy|October 8, 2016
Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinomaHai-Ying Wang, Zhi-Hua Yao, Hong Tang, et al.
American Journal of Cancer Research|March 21, 2020
Tip of the iceberg: roles of circRNAs in hematological malignanciesShan-Shan Guo, Bi-Xia Li, Duo-Bing Zou, et al.
Future Oncology (London, England)|September 22, 2023
A multicenter randomized, controlled clinical trial of adjuvant sintilimab for esophageal squamous cell carcinomaHai-Bo Sun, Wen-Qun Xing, Xian-Ben Liu, et al.
Oncotarget|December 1, 2016
A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinomaHai-Ying Wang, Zhi-Hua Yao, Hong Tang, et al.
The International Journal of Biological Markers|September 28, 2012
p63 Expression is a prognostic factor in colorectal cancerHong-Qiang Guo, Guo-Liang Huang, Ou-Fei Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 11, 2021
Galangin ameliorates severe acute pancreatitis in mice by activating the nuclear factor E2-related factor 2/heme oxygenase 1 pathwayYao-Dong Song, Yan-Yan Liu, De-Jian Li, et al.
Frontiers in Pharmacology|February 18, 2025
ELABELA promotes the migration and homing of bone marrow mesenchymal stem cells to myocardial injury sites through the ERK1/2/miR-299a-5p/Exo70 pathwayJing-Yu Hou, Hao Wu, Shuang-Mei Li, et al.
Current Medical Science|June 6, 2024
Circ_0012152 Accelerates Acute Myeloid Leukemia Progression through the miR-652-3p/SOX4 AxisYing Chen, Bi-Xia Li, Ting-Ting Niu, et al.
Journal of Cancer Research and Clinical Oncology|April 17, 2021
A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX)Yuan Cheng, Shu-Kui Qin, Jin Li, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Proteomics|July 21, 2012
A novel quantitative proteomics workflow by isobaric terminal labelingShu-Jun Yang, Ai-Ying Nie, Lei Zhang, et al.
Oncotargets and Therapy|October 8, 2016
Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinomaHai-Ying Wang, Zhi-Hua Yao, Hong Tang, et al.
American Journal of Cancer Research|March 21, 2020
Tip of the iceberg: roles of circRNAs in hematological malignanciesShan-Shan Guo, Bi-Xia Li, Duo-Bing Zou, et al.
Future Oncology (London, England)|September 22, 2023
A multicenter randomized, controlled clinical trial of adjuvant sintilimab for esophageal squamous cell carcinomaHai-Bo Sun, Wen-Qun Xing, Xian-Ben Liu, et al.
Oncotarget|December 1, 2016
A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinomaHai-Ying Wang, Zhi-Hua Yao, Hong Tang, et al.
The International Journal of Biological Markers|September 28, 2012
p63 Expression is a prognostic factor in colorectal cancerHong-Qiang Guo, Guo-Liang Huang, Ou-Fei Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 11, 2021
Galangin ameliorates severe acute pancreatitis in mice by activating the nuclear factor E2-related factor 2/heme oxygenase 1 pathwayYao-Dong Song, Yan-Yan Liu, De-Jian Li, et al.
Frontiers in Pharmacology|February 18, 2025
ELABELA promotes the migration and homing of bone marrow mesenchymal stem cells to myocardial injury sites through the ERK1/2/miR-299a-5p/Exo70 pathwayJing-Yu Hou, Hao Wu, Shuang-Mei Li, et al.
Current Medical Science|June 6, 2024
Circ_0012152 Accelerates Acute Myeloid Leukemia Progression through the miR-652-3p/SOX4 AxisYing Chen, Bi-Xia Li, Ting-Ting Niu, et al.
Journal of Cancer Research and Clinical Oncology|April 17, 2021
A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX)Yuan Cheng, Shu-Kui Qin, Jin Li, et al.
Pageof 3